Inventor
MANNING PAMELA T
US19 patents
⚠️ This page may combine multiple inventors who share the name “MANNING PAMELA T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PHARMACIA CORP
7 patentsUS6586474B2Jul 1, 2003
Amidino compounds useful as nitric oxide synthase inhibitors
PHARMACIA CORP46 citations95
US7196118B2Mar 27, 2007
Amidino compounds useful as nitric oxide synthase inhibitors
PHARMACIA CORP24 citations92
US6914158B2Jul 5, 2005
Amidino compounds useful as nitric oxide synthase inhibitors
PHARMACIA CORP17 citations92
US7012098B2Mar 14, 2006
Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers
PHARMACIA CORP29 citations87
US7102013B2Sep 5, 2006
Methods of making amidino compounds useful as nitric oxide synthase inhibitors
PHARMACIA CORP8 citations73
US6465518B2Oct 15, 2002
Halogenated 2-amino-4, 5 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
PHARMACIA CORP9 citations73
US6465686B2Oct 15, 2002
Halogenated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
PHARMACIA CORP10 citations72
ARCH ONCOLOGY INC
7 patentsUS10259873B2Apr 16, 2019
Therapeutic CD47 antibodies
ARCH ONCOLOGY INC21 citations93
US10844124B2Nov 24, 2020
Therapeutic CD47 antibodies
ARCH ONCOLOGY INC6 citations80
US10239945B2Mar 26, 2019
Therapeutic CD47 antibodies
ARCH ONCOLOGY INC13 citations80
US10676524B2Jun 9, 2020
Therapeutic CD47 antibodies
ARCH ONCOLOGY INC2 citations72
US10669336B2Jun 2, 2020
Therapeutic CD47 antibodies
ARCH ONCOLOGY INC4 citations72
US11292834B2Apr 5, 2022
Therapeutic CD47 antibodies
ARCH ONCOLOGY INC0 citations61
US11692035B2Jul 4, 2023
Therapeutic CD47 antibodies
ARCH ONCOLOGY INC0 citations48